GlassScriptPhysician profile
Amada Mendoza
NPI 1013059062
$2,773.62
in general payments reported to CMS, 2019-2025
19 companies · $1,364 in 2025
The $1,364 reported for 2025 was more than what 97% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $401 · 2022: $318 · 2023: $249 · 2024: $442 · 2025: $1,364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,054.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,053.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $944.01 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Sage Therapeutics, LLC | $299.51 | 2024-2025 | Zurzuvae |
| Organon LLC | $249.43 | 2021-2025 | Nexplanon |
| Glaxosmithkline, LLC. | $236.34 | 2021-2025 | Bexsero |
| Shield Therapeutics INC | $202.52 | 2023-2025 | Accrufer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.68 | 2025 | Jardiance |
| Merck Sharp & Dohme LLC | $119.71 | 2021-2025 | Vaxneuvance, Capvaxive, Gardasil 9 |
| Biogen, INC. | $114.21 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $96.72 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $63.70 | 2022-2025 | |
| Sanofi Pasteur INC. | $59.21 | 2022-2024 | |
| Supernus Pharmaceuticals, INC. | $43.17 | 2025 | Qelbree |
| Hologic Sales and Service, LLC | $41.19 | 2024-2025 | Thinprep 2000 Processor, Aptima |
| Amarin Pharma, INC. | $37.95 | 2021 | |
| Lilly USA, LLC | $32.73 | 2025 | Jardiance, Mounjaro, Zepbound |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $25.10 | 2021 | |
| Pfizer INC. | $21.11 | 2025 | |
| Phadia US INC. | $16.65 | 2023 | Immunocap |
| Cranial Technologies, INC | $14.68 | 2023 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amada Mendoza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.